Story perspectives

Immortal Dragons Invests $40M in Anti-Aging Breakthrough

10/25/2025

27 3

Summary

Story summary

Immortal Dragons, a $40 million longevity fund in Singapore, announced an investment in Unlimited Bio.
Unlimited Bio develops anti-aging therapies, integrating gene therapies and biologics for multi-system aging.
The platform aims to combine interventions to extend the functional lifespan of tissues.
Its initial gene therapy portfolio targets vascular and cognitive applications.
A first-in-human study is planned for late 2025 to early 2026, pending approvals, to assess dual gene-therapy combinations.

1 of 1

Story summary

Immortal Dragons, a $40 million longevity fund in Singapore, announced an investment in Unlimited Bio.
Unlimited Bio develops anti-aging therapies, integrating gene therapies and biologics for multi-system aging.
The platform aims to combine interventions to extend the functional lifespan of tissues.
Its initial gene therapy portfolio targets vascular and cognitive applications.
A first-in-human study is planned for late 2025 to early 2026, pending approvals, to assess dual gene-therapy combinations.